CRP induction in tamoxifen-resistant breast cancer cells

被引：0
|
作者：
Choi, Min Chang [1 ,2 ]
Moon, Aree [3 ]
Kang, Keon Wook [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea
[3] Duksung Womens Univ, Coll Pharm, Seoul, South Korea
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
710
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Activation of VEGF signaling pathways in tamoxifen-resistant breast cancer cells
    Scherbakov, AM
    Krasilnikov, MA
    Gershtein, ES
    [J]. FEBS JOURNAL, 2005, 272 : 445 - 446
  • [12] Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
    Steifensand, Friederike
    Gallwas, Julia
    Bauerschmitz, Gerd
    Gruendker, Carsten
    [J]. CELLS, 2021, 10 (09)
  • [13] Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
    Nguyen Thi Thuy Phuong
    Kim, Sang Kyum
    Lim, Sung Chul
    Kim, Hyung Sik
    Kim, Tae Hyung
    Lee, Kwang Yeol
    Ahn, Sang-Gun
    Yoon, Jung-Hoon
    Kang, Keon Wook
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 73 - 83
  • [14] Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
    Moon, Seo Yun
    Lee, Heejin
    Kim, Seoree
    Hong, Ji Hyung
    Chun, Sang Hoon
    Lee, Hee Yeon
    Kang, Keunsoo
    Kim, Ho Shik
    Won, Hye Sung
    Ko, Yoon Ho
    [J]. BMC CANCER, 2021, 21 (01)
  • [15] An epigenomic approach to therapy for tamoxifen-resistant breast cancer
    Qin Feng
    Zheng Zhang
    Martin J Shea
    Chad J Creighton
    Cristian Coarfa
    Susan G Hilsenbeck
    Rainer Lanz
    Bin He
    Lei Wang
    Xiaoyong Fu
    Agostina Nardone
    Yongcheng Song
    James Bradner
    Nicholas Mitsiades
    Constantine S Mitsiades
    C Kent Osborne
    Rachel Schiff
    Bert W O'Malley
    [J]. Cell Research, 2014, 24 : 809 - 819
  • [16] Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
    Seo Yun Moon
    Heejin Lee
    Seoree Kim
    Ji Hyung Hong
    Sang Hoon Chun
    Hee Yeon Lee
    Keunsoo Kang
    Ho Shik Kim
    Hye Sung Won
    Yoon Ho Ko
    [J]. BMC Cancer, 21
  • [17] An epigenomic approach to therapy for tamoxifen-resistant breast cancer
    Feng, Qin
    Zhang, Zheng
    Shea, Martin J.
    Creighton, Chad J.
    Coarfa, Cristian
    Hilsenbeck, Susan G.
    Lanz, Rainer
    He, Bin
    Wang, Lei
    Fu, Xiaoyong
    Nardone, Agostina
    Song, Yongcheng
    Bradner, James
    Mitsiades, Nicholas
    Mitsiades, Constantine S.
    Osborne, C. Kent
    Schiff, Rachel
    O'Malley, Bert W.
    [J]. CELL RESEARCH, 2014, 24 (07) : 809 - 819
  • [18] COUP-TFII in tamoxifen-resistant breast cancer
    Klinge, Carolyn M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S29 - S29
  • [19] Experimental Study on Inhibition of Bioactivity of Tamoxifen-Resistant Breast Cancer Cells by Emodin
    Chen, Xu
    Yao, Chang
    [J]. JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (03) : 342 - 349
  • [20] Cellular fatty acid uptake is enhanced in tamoxifen-resistant breast cancer cells
    Hwang, Sewon
    Lee, Mi-Ock
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345